欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4236/002
药品名称Bortezomib Sandoz
活性成分
    • Bortezomib 3.5 mg
剂型Powder for solution for injection
上市许可持有人Sandoz B.V., The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Bortezomib Sandoz 3,5 mg poeder voor oplossing voor injectie
互认成员国 - 产品名称
    • Germany (DE)
      Bortezomib HEXAL 3,5 mg
    • Iceland (IS)
      Bortezomib Sandoz 3,5 mg Stungulyfsstofn, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Italy (IT)
    • France (FR)
    • Greece (GR)
    • Norway (NO)
    • Hungary (HU)
      BORTEZOMIB SANDOZ 3,5 mg por oldatos injekcióhoz
    • Bulgaria (BG)
      Bortezomib Zandoz
    • Slovenia (SI)
      Bortezomib Sandoz 3,5 mg prašek za raztopino za injiciranje
    • Portugal (PT)
许可日期2018/03/09
最近更新日期2025/01/20
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase